In cancer type stratification analysis, the CASP8 -652 6N ins/del polymorphism decreased risk for colorectal cancer, breast cancer, esophageal cancer, renal cell carcinoma, lung cancer, cervical cancer, bladder cancer, gastric cancer, and other cancers. The gene discussed is CASP8; the disease is urinary bladder carcinoma.